Systemic Psoriasis Therapeutics: Increased Disease Awareness and Promising Novel Drugs to Drive Market Growth by 2020, More information visit- http://mrr.cm/Zky

1. Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com

2. Introduction to Report
 Launch Date: February 7, 2014
 Number of Pages: 101
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 3,500
Price For Site License: USD 7,000
Price For Global User License: USD 10,500
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com

3. About the Report
The systemic psoriasis treatment market value in the
eight major countries (8MM) — the US, Canada, France,
Germany, Italy, Spain, the UK and Japan — is expected to
more than double in the near future, jumping from $5
billion in 2013 to $10.4 billion by 2020, at a significant
Compound Annual Growth Rate (CAGR) of 11.1%.
The report states that across the 8MM, 4.1 million people
were diagnosed with some form of moderate-to-severe
psoriasis in 2013. This number is expected to climb
slightly to 4.4 million by 2020, with 1.5 million of the
population being treated with systemic agents.
www.MarketResearchReports.com

4. Research Findings
Leading analyst of the research team says: “This growth
in the treatment population will be driven by a marginal
rise in the global prevalence of psoriasis, as well as an
increase in the diagnosis rate resulting from higher
disease awareness and improved diagnostic methods.
“Additionally, psoriasis is increasingly being recognized
as a serious systemic disease with associated quality of
life impairment and disability, rather than as a simply
cutaneous disease. As perceptions of psoriasis continue to
change, healthcare professionals will consider treatment
as non-optional.”
www.MarketResearchReports.com

5. Research Findings Continues…
Although some revenue losses are anticipated to occur
throughout the forecast period, due to patent expiries,
the introduction of new, novel biologics with positive
efficacy profiles will drive further market growth.
According to report, secukinumab, brodalumab and
ixekizumab are three particularly promising, late-stage
pipeline monoclonal antibodies directly targeting IL–17, a
pro-inflammatory cytokine. In addition to these upcoming
biologics, some orally administered, small molecule
compounds are also expected to enter the market over
the coming years, such as Xeljanz, a janus kinase inhibitor,
and apremilast, a PDE4 inhibitor.
www.MarketResearchReports.com

6. Scope
An
introduction
to
psoriasis,
which
includes
symptoms, epidemiology, etiology, pathophysiology, diagnosis
and treatment
Analysis of the major systemic therapies in the current psoriasis
marketed landscape
Analysis of the pipeline for psoriasis, which includes a
breakdown
of
pipeline
molecules
by
phase
of
development, molecule type, molecular target and novelty.
Psoriasis clinical trials are analyzed by size, duration and failure
rates, and a comparative analysis of the most promising systemic
pipeline molecules is also provided.
Forecast projections for the systemic psoriasis market to 2020.
Analysis is provided for the global market and each of the eight
major markets. The forecast incorporates projected, low and
high variance scenarios based on treatment usage patterns and
annual therapy costs in each of the major markets.
Analysis of strategic consolidations, including co-development
and licensing deals, within the psoriasis indication
www.MarketResearchReports.com

7. Reasons To Buy
Understand the current systemic psoriasis marketed
products landscape and recognize the dominant
therapeutic agents and pharmaceutical players involved
Identify trends and developments within the psoriasis
pipeline and consider how the future competitive
environment will be impacted
Consider market opportunities and potential risks by
examining the psoriasis clinical trial landscape in relation
to industry averages
Observe
projections
for
treatment
usage
patterns, annual therapy costs and market growth in the
eight major markets and understand reasons for variance
in projected patterns of growth in the eight major
markets
www.MarketResearchReports.com

8. Report Coverage
1.
2.
3.
4.
5.
6.
7.
Table of Contents
Introduction
Marketed Products
Pipeline
Market Forecast to 2020
Co-development and Licensing deals
Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com

9. Custom Research:
 Are you an industry
professional, entrepreneur, venture capitalist, investors
and organization, then let us know your specific
research requirements. Our goal is to cater to your
requirements be it for a custom market research
project, syndicated research report on a specific market
or industry sector, newsletter creation, case study
development or anything else related to marketing
research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com

10. How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://www.marketresearchreports.com/gbiresearch/systemic-psoriasis-therapeutics-majordeveloped-markets-2020-continued-uptake-biologics
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)
www.MarketResearchReports.com